期刊文献+

冠心病患者外周血单个核细胞源树突状细胞基因表达差异的研究 被引量:1

Study on the genes expression profile of monocyte derived dendritic cells from patients with coronary heart disease by gene array
原文传递
导出
摘要 目的:体外培养冠心病患者外周血单个核细胞来源的树突状细胞(dendritic cells,DCs),并利用基因芯片技术对冠心病患者外周血培养的DC功能基因表达谱进行研究。方法:分别配对筛选急性冠状动脉综合征患者(ACS)及冠状动脉正常的胸痛综合征患者各5例,将人外周血分离的单个核细胞加入包含rhGM-CSF(20μg/L)和rhIL-4(20μg/L)的培养基中培养,使其分化为DCs。再用基因芯片技术检测DC特异性功能蛋白基因表达的变化。结果:ACS组功能蛋白表达基因中有5个基因呈明显上升,分别是G1P2、G1P3、IFIT4、IL-1β和MX1,这些都是高度相关的干扰素诱导蛋白基因。有17个基因呈明显下降表达,分别是ACPP、AIM2、ATM、CCR1、CCR5、CD1C、FCGR3A、IFI16、IL-16、IL-18、LY75、MAP4K3、TAP1、TAP2、TLR1、TNFRSF6和VCL等,分别属于抗原识别受体、细胞趋化因子受体、细胞因子和细胞内信号传导系统。结论:冠心病患者外周血单个核细胞来源的DC不但在形态和表型上存在明显差异,而且在功能蛋白表达方面也存在显著变化。 Objective:To study the genes expression profile of monocyte derived dendritic cells from patients with coronary heart disease by Gene array. Method:Five matched-pairs were screened from patients with acute coronary syndrome and people with chest pain but normal coronary arteries. DCs derived from peripheral blood monocytes ( PBMCs) were isolated and cultured in vitro with rhGM-CSF (20 ng/ml)and rh IL-4 (20 ng/ml). the DCs' expression profile of cytokine and signal transduction genes were examined by the gene array. Results:Detection by Gene array showed that 5 functional expression genes,including G1P2,G1P3,IFIT4,IL-1β and MX1,increased obviously in ACS cases. All they are the highly correlated interferon-induced protein genes. 17 genes,including ACPP,AIM2,ATM,CCR1,CCR5,CD1C,FCGR3A,FI16,IL-16,IL-18,LY75,MAP4K3,TAP1,TAP2,TLR1,TNFRSF6 and VCL,expression levels decreased obviously. They belong to antigen recognition receptors,cell chemokine receptors,cytokines and intracellular signal transducting system,respectively. Conclusion:The results suggested that the Genes Expression Profile of DCs from patients with ACS were different from people with CPS. This indicated that DCs may play the important role in the form of atherosclerosis.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2010年第1期7-10,共4页 Journal of Clinical Cardiology
关键词 冠心病 树突状细胞 动脉粥样硬化 基因芯片 细胞因子 atherosclerosis dendritic cells gene array cytokine
  • 相关文献

参考文献5

二级参考文献42

  • 1Ishida H,Ota H,Yanagida H,et al.An imbalance between Th1and Th2-like cytokines in patients with autoimmune diseasesdifferential diagnosis between Th1 dominant autoimmune diseases and Th2 dominant autoimmune diseases.Nippon Rinsho,1997,55: 1438-1443.
  • 2Scheele J,Pasillas M,Kamps HP.Transcriptional profiling during the early differentiation of granulocyte and monocyte progenitors controlled by conditional versions of the E2a-Pbxl oncoprotein.Leuk Lymphoma,2003,44:1187-1199.
  • 3McCaffrey AP,Meuse L,Pham TTT,et al.RNA interference in adult mice.Nature,2002,418: 38-39.
  • 4Ye S,Pang H,Gu YY,et al.Protein interaction for an interferoninducible systemic lupus associated gene,IFIT1.Rheumatology (Oxford),2003,42:1155-1163.
  • 5Xia HB.SiRNA-mediated gene silencing in vitro and in vivo.Nature Biotechnology,2002,20: 1006-1010.
  • 6Han GM,Chen SL,Shen N,et al.Analysis of gene expression profiles in human systemic lupus erythematosus using oligonucleotide microarray.Genes lmmun,2003,4: 177-186.
  • 7de Veer MJ,Sim H,Whisstock JC,et al.IFI60/ISG60/IFIT4,a new member of the human IFI54/IFIT2 family of interferonstimulated genes.Genomics,1998,54: 267-277.
  • 8Kato A,Homma J,Batehelor J,et al.Interferon-alpha/beta receptor-mediated selective induction of a gene cluster by CpG oligodeoxynucleotide 2006.BMC Immunol,2003,30: 8.
  • 9Ibashir SM.Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells.Nature,2001,411: 494-498.
  • 10Brummelkamp TR,Bernards R,Agami R.A system for stable expression of short interference RNAs in mammalian cells.Science,2002,296: 550-553.

共引文献29

同被引文献29

  • 1Daugherty A, Dunn JL, Rateri DL, et al. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions[J]. J Clin Invest, 1994,94 ( 1 ) : 437-444.
  • 2Brennan ML, Hazen S. Emerging role of myeloperoxidase an oxidant stress markers in cardiovascular risk assessment [J].Curr Opin Lipidol, 2003,14(4): 353-359.
  • 3Nicholls SJ, Hazen SL. The role of myeloperoxidase in the pathogenesis of coronary artery disease[J]. Jpn J Infect Dis, 2004,57 (suppl 5) :21-22.
  • 4Baldus S, Heeschen C, Meinertz T, et al. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes[J]. Circulation, 2003,108(12) : 1440-1445.
  • 5Meuwese MC, Stroes ES, Hazen SL, et al. Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population Study[J]. J Am Coll Cardiol, 2007,50(2): 159-165.
  • 6Ada S, Siegmund B, Gjin N, et al. Prognostic value of plasma myeloperoxidase concentration in patients with stable coronary artery disease[J].Am Heart J,2008,155(2):356-360.
  • 7Stanley L. Hazen. Myeloperoxidase and plaque vulnerability[J]. Arterioscler Thromb Vase Biol, 2004,24 (7) : 1143-1146.
  • 8Libby P, Ridker PM, Hansson GK, etal. Inflammation in atherosclerosis: from pathophysiology to practice[J].J Am Coll Cardiol,2009,54(23):2129-2138.
  • 9Galkina E, Ley K. Immune and inflammatory mechanisms of atherosclerosis[J].Annu Rev Immunol,2009,27(1):165-197.
  • 10Schindhelm RK, van der Zwan LP, Teerlink T, et al. Myeloperoxidase: a useful biomarker for cardiovascular disease risk stratification? [J]. Clin Chem,2009,55(8) : 1462-1470.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部